2022
DOI: 10.2147/cmar.s377784
|View full text |Cite
|
Sign up to set email alerts
|

Combination of Changes in CEA and CA199 Concentration After Neoadjuvant Chemoradiotherapy Could Predict the Prognosis of Stage II/III Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision

Abstract: Background Previous studies have shown that the levels of serum tumor markers CEA and CA19-9 were related to chemoradiotherapy. Therefore, it has been assumed that dynamic monitoring of these markers could predict the prognosis of stage II/III rectal cancer (RC). Therefore, this study proposed to evaluate the prognostic value of changes in serum tumor biomarkers for stage II/III RC patients undergoing neoadjuvant chemoradiotherapy (NCRT) followed by total mesorectal excision (TME). … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…Additionally, higher post-CCRT CEA levels were predictive of poor OS. Other studies, such as those by Zhao et al [28] and Lu et al [21] successfully developed scoring systems by combining CEA with other clinical factors, such as CA-199 or nutritional indices, to predict DFS and OS outcomes. These studies collectively underscore the importance of CEA as a prognostic indicator for evaluating treatment response and long-term outcomes in patients with rectal cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, higher post-CCRT CEA levels were predictive of poor OS. Other studies, such as those by Zhao et al [28] and Lu et al [21] successfully developed scoring systems by combining CEA with other clinical factors, such as CA-199 or nutritional indices, to predict DFS and OS outcomes. These studies collectively underscore the importance of CEA as a prognostic indicator for evaluating treatment response and long-term outcomes in patients with rectal cancer.…”
Section: Discussionmentioning
confidence: 99%